scispace - formally typeset
M

Michael R. Sperling

Researcher at Thomas Jefferson University

Publications -  695
Citations -  36777

Michael R. Sperling is an academic researcher from Thomas Jefferson University. The author has contributed to research in topics: Epilepsy & Temporal lobe. The author has an hindex of 87, co-authored 637 publications receiving 31001 citations. Previous affiliations of Michael R. Sperling include University of Western Ontario & University of Arizona.

Papers
More filters
Journal ArticleDOI

Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy

Robert S. Fisher, +141 more
- 01 May 2010 - 
TL;DR: A multicenter, double‐blind, randomized trial of bilateral stimulation of the anterior nuclei of the thalamus for localization‐related epilepsy is reported.
Journal ArticleDOI

Analysis of shared heritability in common disorders of the brain

Verneri Anttila, +720 more
- 22 Jun 2018 - 
TL;DR: It is demonstrated that, in the general population, the personality trait neuroticism is significantly correlated with almost every psychiatric disorder and migraine, and it is shown that both psychiatric and neurological disorders have robust correlations with cognitive and personality measures.
Journal ArticleDOI

Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy: A Randomized Trial

TL;DR: Whether surgery soon after failure of 2 antiepileptic drug (AED) trials is superior to continued medical management in controlling seizures and improving quality of life (QOL) is sought and among patients with newly intractable disabling MTLE, resective surgery plus AED treatment resulted in a lower probability of seizures during year 2 of follow-up than continued AEDtreatment alone.
Journal ArticleDOI

Proposal for a New Classification of Outcome with Respect to Epileptic Seizures Following Epilepsy Surgery

TL;DR: This poster presents a poster presented at the annual meeting of the American Academy of Neurology, where it was presented for the first time with a focus on the treatment of seizure-like symptoms in patients with epilepsy.